Diagnosis of Invasive Pulmonary Aspergillosis.

[1]  H. Ozkan,et al.  Serum galactomannan levels in the diagnosis of invasive aspergillosis , 2015, The Korean journal of internal medicine.

[2]  Mahesh Anantha Narayanan,et al.  Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature , 2015, Case reports in infectious diseases.

[3]  M. Pehlivan,et al.  Investigating the presence of fungal agents in febrile neutropenic patients using different microbiological, serological, and molecular methods. , 2015, Bosnian journal of basic medical sciences.

[4]  R. Agarwal,et al.  Acute Invasive Pulmonary Aspergillosis Complicating Allergic Bronchopulmonary Aspergillosis: Case Report and Systematic Review , 2015, Mycopathologia.

[5]  M. Campos,et al.  Invasive Fungal Infections After Kidney Transplantation: A Single-center Experience. , 2015, Transplantation proceedings.

[6]  A. Nicholson,et al.  A comprehensive diagnostic approach using galactomannan, targeted β‐d‐glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients , 2015, British journal of haematology.

[7]  P. White,et al.  New fungal diagnostics. , 2014, British journal of hospital medicine.

[8]  G. Desoubeaux,et al.  Diagnosis of invasive pulmonary aspergillosis: updates and recommendations. , 2014, Medecine et maladies infectieuses.

[9]  C. Heussel,et al.  Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation , 2011, British journal of haematology.

[10]  A. Soubani,et al.  Pulmonary aspergillosis: a clinical review , 2011, European Respiratory Review.

[11]  C. Cordonnier,et al.  Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  T. Walsh,et al.  Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  K. Theunissen,et al.  Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders , 2007, Mycoses.

[15]  J. Fine,et al.  Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Peter Shaw,et al.  Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia , 2005, British journal of haematology.

[17]  G. Verhoef,et al.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  W. Leisenring,et al.  Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Kalkancı,et al.  Polymerase chain reaction in the diagnosis of invasive aspergillosis , 2004, Mycoses.

[20]  Nina Singh,et al.  Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum , 2004, Antimicrobial Agents and Chemotherapy.

[21]  B. Wong,et al.  Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections , 2002, Clinical Microbiology Reviews.

[22]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.